United Kingdom· GB-APID-9903711000001109
Menitorix vaccine powder and solvent for solution for injection 0.5ml vials
A medicinal product containing haemophilus influenzae type b + meningococcal group c vaccine, registered in United Kingdom by GlaxoSmithKline UK Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Haemophilus influenzae type b + Meningococcal group C vaccine
- Manufacturer
- GlaxoSmithKline UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin5000123112159
- gtin5000123114160
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d2f66f76-06e5-4a15-946b-cc205e6548d2 GET /v1/drugs/d2f66f76-06e5-4a15-946b-cc205e6548d2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "9903711000001109",
"desc": "Menitorix vaccine powder and solvent for solution for injection 0.5ml vials (GlaxoSmithKline UK Ltd)",
"form": "Powder and solvent for solution for injection",
"vpid": "9904411000001100",
"source": "dmd",
"vtm_id": "10201211000001100",
"strength": null,
"substance": "Haemophilus influenzae type b + Meningococcal group C vaccine",
"ingredient": "Haemophilus influenzae type b polysaccharide tetanus toxoid conjugate",
"supplier_code": "4012301000001105"
}See everything about haemophilus influenzae type b + meningococcal group c vaccine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.